Proliferative activity and steroid hormone receptor status in male breast carcinoma

Journal of Steroid Biochemistry and Molecular Biology

Volumn 67, Issue 4, 1998, Pages 333-339

  Muñoz De Toro, Mónica M ^a   Maffini, Maricel V ^a   Kass, Laura ^a   Luque, Enrique H ^a  

^a UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CYCLINE; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER INCIDENCE; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; MALE; MITOSIS RATE; ONSET AGE; PHENOTYPE; PROGNOSIS;

BIOLOGICAL MARKERS; BREAST NEOPLASMS, MALE; CELL DIVISION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0032212998     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(98)00124-1     Document Type: Article

References (41)

1. 1. Donegan W. L. and Redlich P. N., Breast cancer in men. Surgical Clinics of North America 76 (1996) 343-363.
2. 2. Gattuso P., Reddy V. B., Green L., Castelli M., Haley D. and Herman C. H., Prognostic significance of DNA ploidy in male breast carcinoma: a retrospective analysis of 32 cases. Cancer 70 (1992) 777-780.
3. 3. Hatschek T., Wingren S., Carstensen J. and Hultbom R., DNA content and S-phase fraction in male breast carcinomas. Acta Oncologica 33 (1994) 609-613.
4. 4. Pich A., Margaria E., Chiusa L., Ponti R. and Geuna M., DNA ploidy and p53 expression correlate with survival and cell proliferative activity in male breast carcinoma. Human Pathology 27 (1996) 676-682.
5. 5. Thomas D. B., Male breast cancer. Epidemiology Reviews 15 (1993) 220-231.
6. 6. Sunderland M. C. and McGuire W. L., Hormones and breast cancer. Trends in Endocrinology and Metabolisms 2 (1991) 72-76.
7. 7. Sasano H., Kimura M., Shizawa S., Kimura N. and Nagura H., Aromatase and steroid receptors in gynecomastia and male breast carcinoma: An immunohistochemical study. Journal of Clinical Endocrinology and Metabolisms 81 (1996) 3063-3067.
8. 8. Munoz de Toro M. and Luque E. H., Lack of relationship between the expression of hsp27 heat shock estrogen receptor-associated protein and estrogen receptor or progesterone receptor status in male breast carcinoma. Journal of Steroid Biochemistry and Molecular Biology 60 (1997) 277-284.
9. 9. Kalkhoven E., Kwakkenbos-Isbrücker L., De Laat S. W., Van Der Saag P. T. and Van Der Burg B., Synthetic progestins induce proliferation of breast tumor cell lines via the progesterone or estrogen receptor. Molecular and Cell Endocrinology 102 (1994) 45-52.
10. 10. Ballare C., Bravo A. I., Sorin I., Guman N., Schiaffi J. A., Yomha R., Bagnati A., Lema B. and Mordoh J., The expression of progesterone receptors coincides with an arrest of DNA synthesis in human breast cancer. Cancer 67 (1991) 1352-1358.
11. 11. Lobaccaro J. M., Lumbroso S., Belon C., Galtier-Dereure F., Bringer J., Lesimple T., Namer M., Cutuli B. F., Pujol H. and Sultan C. H., Androgen receptor gene mutation in male breast cancer. Human Molecular Genetics 2 (1993) 1799-1802.
12. 12. Szelei J., Jimenez J., Soto A. M., Luizzi M. F. and Sonnenschein C., Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor. Endocrinology 138 (1997) 1406-1412.
13. 13. Le Doussal V., Tubiana-Hulin M., Friedman S., Hacene K., Spyratos F. and Brunet M., Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer 64 (1989) 1914-1921.
14. 14. Elston C. W., Grading of invasive carcinoma of the breast. In Diagnostic Histopathology of the Breast, ed. D. L. Page and T. J. Anderson. Churchill Livingstone, Edinburgh, 1987, pp. 300-311.
15. 15. Baak J. P. A., Mitosis counting in tumors. Human Pathology 21 (1990) 683-685.
16. 16. Muñoz de Toro M. and Luque E. H., Effect of microwave pretreatment on proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections. Journal of Histotechnology 18 (1995) 11-16.
17. 17. Elias J. M., Margiotta M. and Gabore B. C., A comparison of the peroxidase-antiperoxidase (PAP), avidin-biotin complex (ABC), and labeled avidin-biotin (LAB) methods for detection of glucagon in paraffin embedded human pancreas. American Journal of Clinical Pathology 92 (1989) 62-67.
18. 18. Allred D. C., Clark G. M., Elledge R., Fuqua S. A. W., Brown R. W., Chamness G. C., Osborne C. K. and McGuire W. L., Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. Journal of the National Cancer Institute 85 (1993) 200-206.
19. 19. Tahan S. R., Neuberg D. S., Dieffenbach A. and Yacoub L., Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score. Cancer 71 (1993) 3552-3559.
20. 20. Siegel, S., Nonparametric Statistics for the Behavioral Sciences. McGraw-Hill, New York, 1956.
21. 21. NIH Consensus Conference, Treatment of early-stage breast cancer. Journal of the American Medical Association, 265 (1991) 391-395.
22. 22. McGuire W. L. and Clark G. M., Prognostic factors and treatment decisions in axillary-node-negative breast cancer. New England Journal of Medicine 326 (1992) 1756-1761.
23. 23. Woosley J. T., Measuring cell proliferation. Archives of Pathology and Laboratory Medicine 115 (1991) 555-557.
24. 24. Keshgegian A. A. and Cnaan A., Proliferation markers in breast carcinoma: Mitotic figures count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1. American Journal of Clinical Pathology 104 (1995) 42-49.
25. 25. Dietrich D. R., Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation. Critical Review of Toxicology 23 (1993) 77-109.
26. 26. Joshi M. G., Lee A. K. C., Loda M., Camus M. G., Pedersen C., Heatley G. J. and Hughes K. S., Male breast carcinoma: An evaluation of prognostic factors contributing to a poorer outcome. Cancer 77 (1996) 490-498.
27. 27. Weber-Chappuis K., Bieri-Burger S. and Hurlimann J., Comparison of prognostic markers detected by immunohistochemistry in male and female breast carcinomas. European Journal of Cancer 32A (1996) 1686-1692.
28. 28. Luque E. H. and Muñoz de Toro M., Male breast carcinoma: Prognostic and predictive indicators related with its biological behavior. Medicina (Bs. As.) 58 (1998) 95-106.
29. 29. Heller K. S., Rosen P. P. and Schottenfeld D., Male breast cancer: A clinicopathologic study of 97 cases. Annals of Surgery 188 (1978) 60-65.
30. 30. Ciatto S., Iossa A. and Bonardi R., Male breast carcinoma: Review of a multicenter series of 150 cases. Tumori 76 (1990) 555-558.
31. 31. Salvadori B., Saccozzi R., Manzari A., Andreola S., Conti R. A., Cusumano F. and Grassi M., Prognosis of breast cancer in males: An analysis of 170 cases. European Journal of Cancer 30 (1994) 930-935.
32. 32. Dickson R. B. and Lippman M. E., Growth factors in breast cancer. Endocrine Reviews 16 (1995) 559-589.
33. 33. Dressier L. G., Seamer L. C., Owens M. A., Clark G. M. and McGuire W. L., DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 61 (1988) 420-427.
34. 34. Meyer J. S., Koehm S. L., Hughes J. M., Higa E., Wittliff J. L., Lagos J. A. and Manes J. L., Bromodeoxyuridine labeling for S-phase measurement in breast carcinoma. Cancer 71 (1993) 3531-3540.
35. 35. Meyer J. S. and Province M. A., S-phase fraction and nuclear size in long term prognosis of patients with breast cancer. Cancer 74 (1994) 2287-2299.
36. 36. Fanelli M. A., Vargas-Roig L. M., Gago F. E., Tello O., De Angelis R. L. and Ciocca D. R., Estrogen receptors, progesterone receptors, and cell proliferation in human breast cancer. Breast Cancer Research and Treatment 37 (1996) 217-228.
37. 37. Russo J. and Russo I. H., Role of differentiation in the pathogenesis and prevention of breast cancer. Endocrine-Related Cancer 4 (1997) 7-21.
38. 38. Everson R. B., Lippman M. E., Thompson E. B., McGuire W. L., Wittliff J. L., De Sombre E. R., Jensen E. V., Shinghakowinta A., Brooks S. C. and Neifeld J. P., Clinical correlations of steroid receptors and male breast cancer. Cancer Research 40 (1980) 991-997.
39. 39. Hackenberg R. and Schulz K.-D., Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen-and androgen-like steroids. Journal of Steroid Biochemistry and Molecular Biology 56 (1996) 113-117.
40. 40. Lemieux P. and Fuqua S., The role of the estrogen receptor in tumor progression. Journal of Steroid Biochemistry and Molecular Biology 56 (1996) 87-91.
41. 41. Hutter R. V. P., The role of the pathologist in breast cancer management. Cancer 66 (1990) 1363-1372.